IMCDII

IMCD

119.50EURD
−0.50−0.42%
At close at May 30, 15:35 GMT
EUR
No trades
See on Supercharts

IMCD fundamentals

Key facts

Market capitalization‪7.05 B‬EUR
Founded2011
Employees (FY)‪5.13 K‬
CEOMarcus Jordan
About

IMCD NV engages in the sale, marketing, and distribution of specialty chemicals and ingredients. It operates through the following segments: Europe, Middle East, and Africa (EMEA), Americas, Asia-Pacific, and Holding Companies. The EMEA segment includes companies in Europe, Turkey, Israel, United Arab Emirates, and Africa. The Americas segment consists of companies in the United States, Canada, Brazil, Puerto Rico, Chile, Argentina, Uruguay, Colombia, and Mexico. The Asia-Pacific segment comprises companies in Australia, New Zealand, India, Bangladesh, China, Malaysia, Indonesia, Philippines, Thailand, Singapore, Vietnam, Japan, and South Korea. The Holding Companies segment refers to the non-operating companies, including the head office and the regional offices in Singapore and New Jersey. The company was founded in 1995 and is headquartered in Rotterdam, the Netherlands.

Ownership
‪‪59.07 M‬‬
Free Float shares
‪‪58.97 M‬‬ (99.83%)
Closely held shares
‪‪98.70 K‬‬ (0.17%)
Free Float shares
‪‪58.97 M‬‬ (99.83%)
Closely held shares
‪‪98.70 K‬‬ (0.17%)
Capital structure
Market cap
‪‪7.05 B‬‬
Debt
‪‪1.71 B‬‬
Minority interest
‪‪1.38 M‬‬
Cash & equivalents
‪‪525.38 M‬‬
Enterprise value
‪‪8.24 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪7.05 B‬‬
Price to earning ratio (P/E)
24.70x
Price to sales ratio (P/S)
1.46x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
24.70x
Price to sales ratio (P/S)
1.46x
Valuation ratios
‪0.00‬
‪0.55‬
‪1.10‬
‪1.65‬
‪2.20‬
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪8.00‬
‪16.00‬
‪24.00‬
‪32.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪5.5%‬
‪5.8%‬
‪6.1%‬
‪6.4%‬
‪6.7%‬
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪‪600.00 M‬‬
‪‪1.20 B‬‬
‪‪1.80 B‬‬
‪‪2.40 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪600.00 M‬‬
‪‪1.20 B‬‬
‪‪1.80 B‬‬
‪‪2.40 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪600.00 M‬‬
‪‪1.20 B‬‬
‪‪1.80 B‬‬
‪‪2.40 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Specialty Chemicals and Ingredients
Commissions
By country
Period: 2024
Rest of EMEA
Asia-Pacific
North America
Latin America
Netherlands

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
‪0.00‬
‪‪700.00 M‬‬
‪‪1.40 B‬‬
‪‪2.10 B‬‬
‪‪2.80 B‬‬
Actual
Estimate
Earnings
Next:Jul 30, 2025
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
‪0.00‬
‪1.00‬
‪2.00‬
‪3.00‬
‪4.00‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
44.21%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
1.80%
Last payment
2.15
Last ex-date
Apr 29, 2025
Last pay date
May 6, 2025
Dividend history
‪0.80%‬
‪1.05%‬
‪1.30%‬
‪1.55%‬
‪1.80%‬
2020
2021
2022
2023
2024
‪0.00‬
‪0.60‬
‪1.20‬
‪1.80‬
‪2.40‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪‪500.00 M‬‬
‪‪1.00 B‬‬
‪‪1.50 B‬‬
‪‪2.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪800.00 M‬‬
‪‪1.60 B‬‬
‪‪2.40 B‬‬
‪‪3.20 B‬‬
Assets
Liabilities